For the Inventor, By the Inventor

Enter assignee name

Lexington, MA, United States of America

Fractyl Laboratories, Inc.

USPTO Granted Patents = 13

EPO Patents = 5

Trademarks = 10

Forward Citations = 324

Loading Chart...

Loading Chart...

10 inventors (with patents filed for the assignee):

Jay D Caplan (13 out of 40 patents)

Harith Rajagopalan (13 out of 35 patents)

J Christopher Flaherty (13 out of 267 patents)

4. R Maxwell Flaherty (5 out of 40 patents)

5. Mark A Manasas (4 out of 11 patents)

6. Craig Morris Gardner (4 out of 19 patents)

7. Andrew Owen Coats (4 out of 29 patents)

8. Phillip S Levin (2 out of 2 patents)

9. Christopher James Kadamus (2 out of 24 patents)

10. Philip Stephen Levin (2 out of 16 patents)

11. J Christopher Flaherty (24 patents)

12. Phillip Levin (0 patent)

13 patents: Sort by Forward Citations

1. 10987149 - Devices and methods for the treatment of tissue (2021-04-27),

2. 10980590 - Devices and methods for the treatment of tissue (2021-04-20),

3. 10973561 - Ablation systems, devices and methods for the treatment of tissue (2021-04-13),

4. 10959774 - Injectate delivery devices, systems and methods (2021-03-30),

5. 10869718 - Methods and systems for treating diabetes and related diseases and disorders (2020-12-22),

6. 10864352 - Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract (2020-12-15),

7. 10765474 - Injectate delivery devices, systems and methods (2020-09-08),

8. 10610663 - Systems, devices and methods for performing medical procedures in the intestine (2020-04-07),

9. 10349998 - Heat ablation systems, devices and methods for the treatment of tissue (2019-07-16),

10. 10299857 - Methods, systems and devices for reducing the luminal surface area of the gastrointestinal tract (2019-05-28),

11. 10232143 - Systems, devices and methods for the creation of a therapeutic restriction in the gastrointestinal tract (2019-03-19),

12. 9844641 - Systems, devices and methods for performing medical procedures in the intestine (2017-12-19),

13. 9757535 - Systems, devices and methods for performing medical procedures in the intestine (2017-09-12),

Fractyl Laboratories, Inc. is a medical technology company focused on developing novel therapeutics for metabolic diseases. Their pioneering approach involves the use of targeted duodenal mucosal resurfacing (DMR) to improve the health and function of the gastrointestinal tract. By restoring the body's natural metabolic control mechanisms, they aim to provide effective, non-surgical treatments for chronic conditions such as type 2 diabetes and non-alcoholic steatohepatitis (NASH). Through their research and innovative solutions, Fractyl Laboratories strives to transform the lives of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

13 Patents

#56 in Lexington, MA

#1,400 in Massachusetts

#23,148 in US

#43,688 in the World

Lexington, MA, United States of America

Fractyl Laboratories, Inc.

Forward Citations = 324

10 inventors:

Jay D Caplan (13 out of 40 patents)

Harith Rajagopalan (13 out of 35 patents)

J Christopher Flaherty (13 out of 267 patents)

4. R Maxwell Flaherty (5 out of 40 patents)

5. Mark A Manasas (4 out of 11 patents)

Please report any incorrect information to support@idiyas.com

Loading…